Every material Form 8-K CareTrust REIT filed with the SEC in 2026, read and summarized by AI: what happened, the key figures, whether it reads positive or negative for shareholders, and how big a deal it is (impact 1-5). Newest first; each brief links to its own page and to the filing on SEC.gov.
CareTrust REIT reported third quarter 2026 net income of $83.7 million, or $0.35 per diluted share, matching the prior year period. The company also announced an increase to its full-year 2026 guidance midpoints for Normalized FFO and Normalized FAD, and reported significant investment activity including the initial closing of 45 U.K. care homes.
Net income for the quarter ended September 30, 2026, was $83.7 million, or $0.35 per diluted share.
Normalized FFO per diluted share grew 20% year-over-year to $0.54.
Full-year 2026 guidance was updated to project Normalized FFO of approximately $2.08 to $2.09 per share.
The quarterly dividend was maintained at $0.39 per share.
On October 1, 2026, CareTrust completed the purchase of 24 completed UK care homes from LNT Care Developments for £576 million (about $764 million), excluding transaction costs. The company also expects to acquire 21 more homes under development for £504 million (about $669 million) on a rolling basis through December 31, 2027, and raised its full-year 2026 guidance, which shareholders may view as a sign of improved earnings expectations.
24 completed care homes acquired October 1, 2026 for £576 million (about $764 million), excluding transaction costs
21 in-development homes to be acquired for £504 million (about $669 million) as they are completed and approved, through December 31, 2027
Full-year 2026 guidance raised: net income attributable to CareTrust of $1.54 to $1.57 per share and Normalized FFO of $2.06 to $2.09 per share
Initial closing funded by proceeds from settling outstanding forward equity agreements and a draw on the revolving credit facility
CareTrust REIT reported second quarter 2026 net income of $89.0 million, or $0.38 per diluted share, up $0.03 or 9% from a year earlier, and Normalized FFO of $119.7 million, or $0.51 per share, up 19%. The company also issued updated 2026 guidance, projecting Normalized FFO of $2.03 to $2.06 per share, which it says represents a 16.2% increase at the midpoint over 2025.
Q2 2026 net income attributable to CareTrust was $89.0 million ($0.38 per diluted share), versus $68.5 million in Q2 2025.
Normalized FFO was $119.7 million ($0.51 per diluted share), up 19% from $0.43 a year earlier.
2026 guidance: Normalized FFO of $2.03 to $2.06 per share and Normalized FAD of $2.01 to $2.04 per share, based on 233 million weighted average diluted shares.
Quarterly dividend of $0.39 per share was declared; the company reported a Net Debt to Annualized Normalized Run Rate EBITDA ratio of 1.01x as of quarter end.
CareTrust REIT reported first-quarter 2026 results that improved from a year earlier and raised its full-year 2026 guidance. Normalized FFO was $0.48 per diluted share, up from $0.42, and the company raised its quarterly dividend to $0.39 per share from $0.335. For shareholders, the filing shows higher earnings per share, a larger dividend and higher projected per-share results for 2026.
Net income attributable to CareTrust was $80.2 million, or $0.36 per diluted share, versus $0.35 a year earlier.
Normalized FFO was $107.4 million, or $0.48 per diluted share, versus $0.42 a year earlier.
2026 guidance: Normalized FFO of $2.00 to $2.04 per share and Normalized FAD of $1.98 to $2.02 per share.
Quarterly dividend increased to $0.39 per share from $0.335 per share.
CareTrust REIT entered a new equity distribution agreement allowing it to sell up to $1,000,000,000 of common stock through a group of sales agents and forward purchasers. The company replaced its prior at-the-market program dated January 21, 2025, and says proceeds would go to its operating partnership for general corporate purposes, including acquisitions and debt repayment. Because new shares would add to the outstanding share count, the program could dilute existing shareholders, though the filing does not state when or whether shares will be sold.
New February 2026 ATM Program covers up to $1,000,000,000 of common stock, $0.01 par value.
Sales agents receive commissions of up to 2.0% of gross sale prices; forward purchasers receive up to 2.0% of the related volume-weighted average price.
Prior program was terminated; $367.0 million of shares remain subject to outstanding forward sale agreements.
Shares are issued under a Form S-3 shelf registration filed February 17, 2026.
CareTrust REIT reported fourth-quarter and full-year 2025 results with higher net income, revenue and per-share normalized FFO than a year earlier. Q4 net income attributable to the company was $111.3 million, or $0.50 per diluted share, compared with $52.1 million a year earlier, and the company issued 2026 guidance for normalized FFO of $1.90 to $1.95 per share. The $0.335 quarterly dividend was maintained.
Q4 2025 net income attributable to CareTrust was $111.3 million, or $0.50 per diluted share, up $0.21 from $0.29 a year earlier.
Q4 normalized FFO was $0.47 per diluted share, up 18%; full-year 2025 normalized FFO was $1.76 per share, up 17%.
2026 guidance projects normalized FFO of $1.90 to $1.95 per share and net income of $1.45 to $1.50 per share, based on 225 million diluted shares.
The company closed $1.8 billion of investments in 2025 at a blended stabilized yield of 8.6%, and reported no borrowings on its $1.2 billion revolving credit facility.
Briefs are written by AI from the filing text (each brief's own page names the model) and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the model's reading of the filing for shareholders, not a price forecast. Not investment advice.
Only material 8-Ks get a brief: results, deals, executive changes, restructuring, impairments, delisting notices, restatements, cybersecurity incidents and other disclosed events. Routine filings (vote results, exhibits only) are skipped. Every CareTrust REIT filing is on SEC EDGAR ↗. 8-K briefs of other companies →